title: Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
abstract: The data presented in this paper demonstrate a new substance P (SP) binding site that is expressed on human monocytes. The apparent dissociation constant (Kd) for binding of 125I-labeled Bolton Hunter-SP (125I-BH-SP) to the receptor on monocyte membranes is 2.24 +/- 0.9 x 10(-7) M and the maximum binding capacity (Bmax) is 4.7 +/- 0.5 pmol/mg membrane protein. It could be excluded that this receptor is one of the known neurokinin (NK) type of receptors on the basis of binding characteristics for NK1, NK2, and NK3 agonists. Moreover, we demonstrate that the binding site is neither the bombesin receptor nor the serpin enzyme complex receptor nor the FMLP receptor. The order of potency for inhibition of 125I-BH-SP binding to the receptor on monocyte membranes is NK1 antagonist [D-Pro2,D-Trp7,9]SP > SP > NK3 agonist [MePhe7]SP > bombesin. Cross-linking studies with disuccinimidylsuberate, followed by SDS-PAGE analysis, revealed that 125I-BH-SP is specifically bound to a membrane protein with an apparent molecular mass of 47 kDa. At a functional level, SP induces the activation of MAP kinase in human monocytes. The ED50 for activation of MAP kinase positively correlated (r = 0.999, p < 0.0005) with the apparent affinity of the ligands applied in the 125I-BH-SP displacement studies. From these results, we conclude that this SP binding site on monocytes is a non-NK receptor protein that is functionally linked to the activation of MAP kinase.
authors.affiliation: Department of Immunology, University Hospital for Children and Youth, Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: Jeurissen
authors.forename: A
authors.initials: A
authors.lastname: Kavelaars
authors.forename: M
authors.initials: M
authors.lastname: Korstjens
authors.forename: D
authors.initials: D
authors.lastname: Broeke
authors.forename: R A
authors.initials: RA
authors.lastname: Franklin
authors.forename: E W
authors.initials: EW
authors.lastname: Gelfand
authors.forename: C J
authors.initials: CJ
authors.lastname: Heijnen
mesh_terms: D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism*; D004789:Enzyme Activation; D006801:Humans; D009000:Monocytes / Q000737:chemistry* / Q000187:drug effects / Q000201:enzymology; D018004:Receptors, Bombesin / Q000032:analysis; D011956:Receptors, Cell Surface / Q000032:analysis; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic / Q000032:analysis; D018040:Receptors, Neurokinin-1 / Q000032:analysis* / Q000502:physiology; D018041:Receptors, Neurokinin-2 / Q000032:analysis; D018042:Receptors, Neurokinin-3 / Q000032:analysis; D018000:Receptors, Peptide / Q000032:analysis; D013373:Substance P / Q000378:metabolism / Q000494:pharmacology
chemical_list: D018004:Receptors, Bombesin; D011956:Receptors, Cell Surface; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D018042:Receptors, Neurokinin-3; D018000:Receptors, Peptide; C064184:serpin-enzyme complex receptor; D013373:Substance P; D017871:Calcium-Calmodulin-Dependent Protein Kinases